To avoid the controversy of bisphosphonate whether it really decreases the markers or because of the normal aging process, a very recent article by Guerin Lemaire et al. (28) used serum periostin level as a biochemical marker to assess the severity and to monitor the treatment in FD. The gene discussed is POSTN; the disease is Fabry disease.